All Stories

  1. Impact of tenofovir vs. entecavir treatment on progression of chronic hepatitis B: A nationwide cohort study

    Article • JHEP Reports, October 2025, Elsevier

    Dr Yi-Wen Huang

  2. Impact of age at HBsAg seroclearance on hepatic outcomes and life expectancy in men with chronic HBV infection based on multi-state modeling of the natural history

    Article • Journal of Gastroenterology, October 2024, Springer Science + Business Media

    Dr Yi-Wen Huang

  3. Trajectories of hepatic steatosis and incidence of cardiovascular disease over a 29‐year follow‐up

    Article • Hepatology Research, August 2024, Wiley

    Dr Yi-Wen Huang

  4. Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry

    Article • Nutrients, August 2024, MDPI AG

    Prof. Loris Pironi, Dr Yi-Wen Huang

  5. Lifetime risk of liver‐related outcomes and determinants in male inactive carriers of chronic hepatitis B

    Article • Journal of Medical Virology, October 2023, Wiley

    Dr Yi-Wen Huang

  6. Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B

    Article • Cancers, December 2022, MDPI AG

    Dr Yi-Wen Huang

  7. Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results

    Article • Pharmaceutics, October 2022, MDPI AG

    Dr Yi-Wen Huang

  8. Novel long‐acting ropeginterferon alfa‐2b: Pharmacokinetics, pharmacodynamics and safety in a phase I clinical trial

    Article • British Journal of Clinical Pharmacology, December 2021, Wiley

    Dr Yi-Wen Huang

  9. Novel Long-Acting Ropeginterferon Alfa-2b: Pharmacokinetics, Pharmacodynamics, and Safety in a Phase I Clinical Trial

    Article • August 2021, Wiley

    Dr Yi-Wen Huang

  10. Pharmacokinetics and Pharmacodynamics of Novel Long-Acting Ropeginterferon Alfa-2b in Healthy Chinese Subjects

    Article • Advances in Therapy, July 2021, Springer Science + Business Media

    Dr Yi-Wen Huang

  11. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis

    Article • Nutrients, November 2017, MDPI AG

    Dr Yi-Wen Huang

  12. Multidisciplinary approach to optimize management of patients with chronic hepatitis C and alcoholic liver disease

    Article • Journal of the Formosan Medical Association, November 2016, Elsevier

    Dr Yi-Wen Huang

  13. Statins and the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients

    Article • The American Journal of Gastroenterology, November 2016, Nature

    Dr Yi-Wen Huang

  14. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

    Article • Liver International, October 2016, Wiley

    Dr Yi-Wen Huang

  15. Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study

    Article • The American Journal of Gastroenterology, May 2016, Nature

    Dr Yi-Wen Huang

  16. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study

    Article • Alimentary Pharmacology & Therapeutics, July 2015, Wiley

    Dr Yi-Wen Huang

  17. Editorial: diabetes and its association with hepatocellular carcinoma in chronic hepatitis B - authors’ reply

    Article • Alimentary Pharmacology & Therapeutics, June 2015, Wiley

    Dr Yi-Wen Huang

  18. HCC in hepatitis B with diabetes

    Article • Alimentary Pharmacology & Therapeutics, April 2015, Wiley

    Dr Yi-Wen Huang

  19. Cirrhosis in hepatitis C with diabetes

    Article • Hepatology, September 2014, Wolters Kluwer Health

    Dr Yi-Wen Huang

  20. P642 LOWER RISK OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN NON-DIABETIC CHRONIC HEPATITIS B PATIENTS WITH NEW ONSET HYPERLIPIDEMIA: A NATIONWIDE COHORT STUDY

    Article • Journal of Hepatology, April 2014, Elsevier

    Dr Yi-Wen Huang

  21. Reduced Toll-like receptor-9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy

    Article • Antiviral Therapy, January 2014, International Medical Press

    Dr Yi-Wen Huang

  22. Reply to: Modulation of Toll-like receptor 9 expression on monocytes of viral hepatitis patients

    Article • Antiviral Therapy, January 2014, International Medical Press

    Dr Yi-Wen Huang

  23. On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy

    Article • Antiviral Therapy, January 2014, International Medical Press

    Dr Yi-Wen Huang

  24. Cirrhosis in hepatitis B with diabetes

    Article • Clinical Infectious Diseases, September 2013, Oxford University Press (OUP)

    Dr Yi-Wen Huang

  25. A Genetic Screen Identifies Interferon-α Effector Genes Required to Suppress Hepatitis C Virus Replication

    Article • Gastroenterology, June 2013, Elsevier

    Dr Wenyu Lin, Dr Yi-Wen Huang

  26. Reduced Toll-like receptor-3 expression in chronic hepatitis B patients and its restoration by interferon therapy

    Article • Antiviral Therapy, January 2013, International Medical Press

    Dr Yi-Wen Huang

  27. Management of hepatitis B reactivation in patients receiving cancer chemotherapy

    Article • Therapeutic Advances in Gastroenterology, June 2012, SAGE Publications

    Dr Yi-Wen Huang

  28. Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients

    Article • Antiviral Therapy, January 2012, International Medical Press

    Dr Yi-Wen Huang

  29. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy

    Article • Antiviral Therapy, January 2011, International Medical Press

    Dr Yi-Wen Huang, Dr Chien-Wei Su

  30. Complications of alcoholic liver cirrhosis: Active assessment by endoscopy and sonography

    Article • Hepatology, June 2010, Wiley

    Dr Yi-Wen Huang

  31. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B

    Article • Antiviral Therapy, January 2010, International Medical Press

    Dr Yi-Wen Huang

  32. Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B

    Article • Antiviral Therapy, January 2010, International Medical Press

    Dr Yi-Wen Huang

  33. Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan

    Article • Genes & Immunity, August 2009, Springer Science + Business Media

    Dr Yi-Wen Huang

  34. Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus

    Article • Journal of Medical Virology, April 2009, Wiley

    Dr Yi-Wen Huang

  35. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series

    Article • Clinical Therapeutics, September 2006, Elsevier

    Dr Yi-Wen Huang

  36. Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B

    Article • Journal of Gastroenterology and Hepatology, May 2006, Wiley

    Dr Yi-Wen Huang